Essra Ridha - Net Worth and Insider Trading

Essra Ridha Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Essra Ridha owns 1 companies in total, including Avrobio Inc (AVRO) .

Click here to see the complete history of Essra Ridha’s form 4 insider trades.

Insider Ownership Summary of Essra Ridha

Ticker Comapny Transaction Date Type of Owner
AVRO Avrobio Inc 2021-10-19 Chief Medical Officer

Essra Ridha Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Essra Ridha Ownership Network

Ownership Network List of Essra Ridha

No Data

Ownership Network Relation of Essra Ridha

Insider Network Chart

Essra Ridha Owned Company Details

What does Avrobio Inc do?

Who are the key executives at Avrobio Inc?

Essra Ridha is the Chief Medical Officer of Avrobio Inc. Other key executives at Avrobio Inc include Chief Technology Officer Azadeh Golipour , Chief Scientific Officer Christopher Mason , and Chief Medical Officer Diana Escolar .

Avrobio Inc (AVRO) Insider Trades Summary

Over the past 18 months, Essra Ridha made no insider transaction in Avrobio Inc (AVRO). Other recent insider transactions involving Avrobio Inc (AVRO) include a net purchase of 766,635 shares made by Braden Michael Leonard ,

In summary, during the past 3 months, insiders sold 0 shares of Avrobio Inc (AVRO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Avrobio Inc (AVRO) were sold and 63,886 shares were bought by its insiders, resulting in a net purchase of 63,886 shares.

Avrobio Inc (AVRO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Avrobio Inc Insider Transactions

No Available Data

Essra Ridha Mailing Address

Above is the net worth, insider trading, and ownership report for Essra Ridha. You might contact Essra Ridha via mailing address: C/o Avrobio, Inc., One Kendall Square, Bldg 300 - Suite 201, Cambridge Ma 02139.